CVS, Walgreens finalize opioid dispute settlement for $10.7B

CVS Health and Walgreens have agreed to pay a total of $10.7 billion to settle opioid disputes, NBC News reported Dec. 12.

The money, which will go to states, local governments and federally recognized tribes, will focus on opioid crisis abatement and remediation programs and settle allegations the companies failed to adequately oversee opioid painkiller prescriptions, thus contributing to America's opioid addiction crisis, the report said.

Walgreens will pay $4.95 billion, plus more than $750 million in fees for attorneys and costs. CVS will pay $4.9 billion to states and political subdivisions and approximately $130 million to tribes.

The money will go to a total of 18 different states, Law 360 said.

The payments, which will be made over time, are some of the final details in the companies' settlement agreements, which were initially revealed in early November, based on company statements. The companies also agreed to implement controlled substance compliance programs and additional training programs for employees. Neither company admits any wrongdoing.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars